SD-101, a novel intratumoral class C CpG-ODN, given with low-dose radiation in patients with untreated low-grade B-cell lymphoma: interim results of a phase I trial Levy, R., Bartlett, N., Friedberg, J., Reagan, P., Gordon, L., Bergman, C., Coffman, R., Janssen, R., Candia, A., Khodadoust, M., Frank, M., Long, S., Czerwinski, D., Chu, M., Kohrt, H. AMER ASSOC CANCER RESEARCH. 2016

View details for DOI 10.1158/1538-7445AM2016-CT047

View details for Web of Science ID 000389940603166